Everything about WB403
information exhibiting TGR5 modulation and GLP-one activation potential, glucose tolerance enhancement, preservation for mass and performance of pancreatic β-cells, and absence of gallbladder filling side effect, represented a promising novel applicant for anti-diabetic drug advancement. The identification and characterization of WB403 not just ad